Altered peptide ligand design: altering immune responses to class I MHC/peptide complexes.
about
Cross-reactivity in T-cell antigen recognition.Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer.Development of the PANVAC-VF vaccine for pancreatic cancer.Secondary anchor substitutions in an HLA-A*0201-restricted T-cell epitope derived from Her-2/neu.PANVAC-VF: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinoma.Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4.Identification of the N-terminal peptide binding site of glucose-regulated protein 94.
P2860
Q34249351-5D519723-D0F7-4470-AF25-496FA6DC7FE1Q36254081-585E1EE4-BCB8-4A78-8D68-80FB08527FCBQ36383786-BC17D109-B6F2-470E-9C1F-A7C5F55A72E8Q36725920-886B73DD-94AE-465A-8312-91AA1FA3E3E7Q36764939-55031060-7376-4B5B-8AD4-7DF26322D762Q40857730-86B4D358-572F-4509-95CC-991146C144F5Q47611234-7594965D-50F2-4984-8D00-B0C6508D914F
P2860
Altered peptide ligand design: altering immune responses to class I MHC/peptide complexes.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Altered peptide ligand design: ...... class I MHC/peptide complexes.
@en
Altered peptide ligand design: ...... class I MHC/peptide complexes.
@nl
type
label
Altered peptide ligand design: ...... class I MHC/peptide complexes.
@en
Altered peptide ligand design: ...... class I MHC/peptide complexes.
@nl
prefLabel
Altered peptide ligand design: ...... class I MHC/peptide complexes.
@en
Altered peptide ligand design: ...... class I MHC/peptide complexes.
@nl
P2860
P1476
Altered peptide ligand design: ...... class I MHC/peptide complexes.
@en
P2093
Collins EJ
Frelinger JA
P2860
P304
P356
10.1111/J.1600-065X.1998.TB01194.X
P577
1998-06-01T00:00:00Z